BNP Paribas Exane Lowers Campbell’s (NASDAQ:CPB) Price Target to $19.00

Campbell’s (NASDAQ:CPB) had its price target cut by stock analysts at BNP Paribas Exane from $22.00 to $19.00 in a research report issued to clients and investors on Thursday, MarketBeat.com reports. The brokerage presently has an “underperform” rating on the stock. BNP Paribas Exane’s price target points to a potential downside of 7.00% from the company’s current price.

Other equities analysts have also issued reports about the company. Sanford C. Bernstein decreased their price target on Campbell’s from $33.00 to $27.00 and set an “outperform” rating for the company in a research note on Thursday, March 12th. Morgan Stanley reduced their price objective on Campbell’s from $27.00 to $25.00 and set an “equal weight” rating for the company in a research note on Thursday, March 12th. Royal Bank Of Canada reduced their target price on Campbell’s from $30.00 to $26.00 and set a “sector perform” rating for the company in a report on Thursday, March 12th. DA Davidson restated a “neutral” rating and issued a $30.00 target price on shares of Campbell’s in a report on Thursday, March 12th. Finally, Jefferies Financial Group restated a “hold” rating and issued a $26.00 target price on shares of Campbell’s in a report on Monday, March 2nd. Two equities research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and eight have issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Reduce” and a consensus price target of $26.89.

Campbell’s Stock Performance

Shares of CPB stock opened at $20.43 on Thursday. Campbell’s has a 12-month low of $20.32 and a 12-month high of $39.04. The firm has a market capitalization of $6.09 billion, a price-to-earnings ratio of 11.16 and a beta of 0.03. The business has a 50 day simple moving average of $24.63 and a 200 day simple moving average of $27.76. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.01 and a quick ratio of 0.51.

Campbell’s (NASDAQ:CPB) last issued its quarterly earnings data on Wednesday, March 11th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.06). Campbell’s had a return on equity of 19.96% and a net margin of 5.48%.The business had revenue of $2.56 billion during the quarter. During the same period last year, the business earned $0.74 earnings per share. Campbell’s’s quarterly revenue was down 4.5% on a year-over-year basis. Campbell’s has set its FY 2026 guidance at 2.150-2.250 EPS. On average, equities research analysts anticipate that Campbell’s will post 3.15 EPS for the current year.

Institutional Investors Weigh In On Campbell’s

Hedge funds and other institutional investors have recently made changes to their positions in the business. Stance Capital LLC acquired a new stake in shares of Campbell’s in the third quarter valued at about $27,000. Flagship Harbor Advisors LLC acquired a new stake in Campbell’s during the fourth quarter worth about $29,000. Sittner & Nelson LLC acquired a new stake in Campbell’s during the fourth quarter worth about $29,000. Los Angeles Capital Management LLC bought a new position in Campbell’s during the fourth quarter worth about $29,000. Finally, Ankerstar Wealth LLC bought a new position in Campbell’s during the fourth quarter worth about $29,000. 52.35% of the stock is owned by institutional investors and hedge funds.

Key Headlines Impacting Campbell’s

Here are the key news stories impacting Campbell’s this week:

• Positive Sentiment: Yahoo’s take: some investors see the share slide as a potential long-term buying opportunity if Campbell’s can stabilize margins and execution — this frames today’s weakness as a possible contrarian entry point. Is Campbell’s (CPB) Share Slide Creating A Long Term Opportunity For Investors
• Neutral Sentiment: Zacks explains recent moves: CPB is down since the earnings miss and softer revenue, and market reaction reflects uncertainty about whether management can meet FY26 guidance and restore growth. Why Is Campbell (CPB) Down 4% Since Last Earnings Report?
• Negative Sentiment: BNP Paribas Exane cut its price target to $19 and moved to underperform, creating fresh analyst-driven downside pressure and signaling low near-term expectations. Campbell’s (NASDAQ:CPB) Price Target Lowered to $19.00 at BNP Paribas Exane
• Negative Sentiment: Coverage consensus has shifted to an overall “reduce” rating, reinforcing selling pressure from multiple brokerages rather than isolated downgrades. The Campbell’s Company (NASDAQ:CPB) Given Average Rating of “Reduce” by Brokerages
• Negative Sentiment: Analyst downgrade(s) pushed CPB to a new 52-week low, a technical trigger that can accelerate selling and hurt sentiment. Campbell’s (NASDAQ:CPB) Hits New 52-Week Low on Analyst Downgrade
• Negative Sentiment: Jim Cramer publicly preferred McCormick over Campbell’s, drawing attention to competitive and margin concerns and likely weighing on retail sentiment. Jim Cramer on the Campbell’s Company: “I’d rather have you own McCormick”
• Negative Sentiment: Finbold highlights that CPB sits near a multi-decade low and revisits reputational headwinds from an executive’s controversial comments late last year — further softening brand perception. Campbell’s Soup stock left simmering near 23-year low

About Campbell’s

Campbell’s (NASDAQ: CPB) is a leading manufacturer of shelf-stable foods and beverages, best known for its iconic soups and broths. Headquartered in Camden, New Jersey, the company offers a diverse portfolio of products designed to meet consumer demand for convenient, affordable meals and snacks. Since its founding in 1869, Campbell’s has grown through a combination of organic innovation and strategic acquisitions to expand its presence in the food industry.

The company’s brand portfolio includes Campbell’s Condensed Soups, V8 juices, Prego pasta sauces, Swanson broths and stocks, Pace salsas and dips, and Pepperidge Farm baked snacks.